HA307-319
| PKYVKQNTLKLAT | Hemagglutinin | HLA-DRB1*07:01 | 25 |
NY-ESO-187-99
| LLEFYLAMPFATP | New York esophageal squamous cell carcinoma 1 | HLA-DRB1*07:01 | 25 |
HA307-319
| PKYVKQNTLKLAT | Hemagglutinin | HLA-DRB1*04:01 | 24 |
MAGE-A3111-125
| RKVAELVHFLLLKYR | Melanoma-associated antigen 3 | HLA-DPB1*04:01 | 75 |
MAGE-A3243-258
| KKLLTQHFVQENYLEY | Melanoma-associated antigen 3 | HLA-DPB1*04:01 | 75 |
TT947-960
| FNNFTVSFWLRVPK | Tetanus toxoid | HLA-DPB1*04:01 | 75 |
Melan-A26-35(A27L)
| ELALIGILTV | MART-1 | HLA-A*02:01 | 44 |
EBV280-288
| GLCTLVAML | BMLF-1 | HLA-A*02:01 | 44 |
CMV495-503
| NLVPMVATV | pp65 | HLA-A*02:01 | 44 |
Influenza matrix protein58-66
| GILGFVFTL | Influenza matrix protein H3N2 | HLA-A*02:01 | 44 |
NY-ESO-1157-165
| SLLMWITQC | New York esophageal squamous cell carcinoma 1 | HLA-A*02:01 | 44 |